More Evidence Diabetes Drug Actos Raises Bladder Cancer Risk a Bit

WEDNESDAY, March 30, 2016 — More evidence linking the diabetes drug Actos to an increased risk of bladder cancer has surfaced in a new study that also finds the risk rises with increased use.
Actos (pioglitazone) appears to increase risk of bladder…
Source: Topamax